COVID-19 vaccine clinical trials: 17 volunteers given doses of Russia's Sputnik V in Pune
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Clinical Trials | COVID-19 | Epidemiology | India Health | Microbiology | Pharmaceuticals | Russia Health | Vaccines